Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Radiology Case Reports|June 2, 2020
Primary pulmonary artery sarcoma in the pediatric patient: Review of literature and a case reportYong Yean Kim, Tung Thanh Wynn, John David Reith, et al.
Nature Communications|July 23, 2024
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcomaMeijie Tian, Jun S Wei, Adam Tai-Chi Cheuk, et al.
Journal of Natural Products|February 18, 2026
Gonystylones A-E, Antiproliferative 5,6-Dihydro-α-pyrones from the Plant Gonystylus borneensisChang-Kwon Kim, Vitor F Freire, Soumili Dey, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 18, 2019
Acute Respiratory Illness in Rural HaitiYong Yean Kim, Judy F Lew, Bahareh Keith, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
RUNX2 inhibition disrupts a PAX3::FOXO1-RUNX2 feed-forward loop and dismantles oncogenic gene programs in fusion-positive rhabdomyosarcomaElizabeth A Mendes, Aanandi Munshi, Archana Singh, et al.
The Journal of Clinical Investigation|July 19, 2022
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastomaMeijie Tian, Adam T Cheuk, Jun S Wei, et al.
Blood Advances|January 6, 2023
A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemiaKatherine E Masih, Rebecca A Gardner, Hsien-Chao Chou, et al.
Cell Reports. Medicine|July 14, 2026
Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancersMeijie Tian, Katrina Jia, Jerry T Wu, et al.
Cell Reports. Medicine|September 29, 2023
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.
Nature Communications|February 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Yean Kim, Berkley E Gryder, Ranuka Sinniah, et al.
Pageof 1